Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants

Mostrar otras versiones (2)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected at least 180 million people since its identification as the cause of the current COVID-19 pandemic. The rapid pace of vaccine development has resulted in multiple vaccines already in use worldwide. The contemporaneous emergenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikegame, Satoshi, Siddiquey, Mohammed N. A., Hung, Chuan-Tien, Haas, Griffin, Brambilla, Luca, Oguntuyo, Kasopefoluwa Y., Kowdle, Shreyas, Chiu, Hsin-Ping, Stevens, Christian S., Vilardo, Ariel Esteban, Edelstein, Alexis, Perandones, Claudia, Kamil, Jeremy P., Lee, Benhur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313705/
https://www.ncbi.nlm.nih.gov/pubmed/34312390
http://dx.doi.org/10.1038/s41467-021-24909-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8313705/
https://www.ncbi.nlm.nih.gov/pubmed/34312390
http://dx.doi.org/10.1038/s41467-021-24909-9

Ejemplares similares